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Dialysis related amyloidosis is the accumulation and deposition of
2-microglobulin derived fibrils in bones and joints, due to insuffi-
cient elimination during therapy or slowly progressing renal fail-
ure. The aim of this study was to analyse biochemical, morphologic
and anamnestic parameters that may be relevant for the onset and
developement of dialysis related amyloidosis. In addition to stan-
dard statistical procedures, we also applied the machine-learning
based methods of data mining to quantify the risk factors for
asymptomatic patients. Extraction of risk factors for the onset of
the dialysis related amyloidosis syndrome could enable the clini-
cian to predict the symptoms and consider medical procedures to
prevent the onset of the disease. The C4.5 machine learning algo-
rithm extracted a simple and highly accurate tree for discrimina-
tion of asymptomatic and symptomatic patients suffering from
dialysis related amyloidosis. It remains an open question if our
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findings may contribute to the problem of accurately predicting the
onset of dialysis related arthropathy in the asymptomatic patient
group.
Key words: dialysis, amyloidosis, biochemistry, morphologic param-
eters, shoulder, knee, symptoms.
INTRODUCTION
Dialysis related amyloidosis is defined as the accumulation and deposi-
tion of 2-microglobulin derived fibrils, especially in bones and joints, due to
insufficient elimination during therapy. The syndrome has also been re-
ported in patients with slowly progressing renal failure who had never been
dialysed.1–3
Amyloidosis in dialysis patients was first linked to osteoarticular syndrom
17 years ago.1 The clinical manifestations were dialysis arthropaty and car-
pal tunnel syndrom. Chronic arthropaty is the term that has also been reported
by many authors.4 Clinical signs of the dialysis related amyloidosis are not
specific in some cases. Typical radiological signs such as amyloid bone cysts
are often late events,4 and capsulosynovial swelling precedes the develop-
ment of characteristic bone cysts, so ultrasound is the method of choice for
observing the early signs.5–13
Shoulder is the joint most frequently involved and changes are present
mainly in tendons and bursae. Opposite results are obtained in the knee where
changes are present primarily in the articular structures.4
Many factors are thought to be related to the syndrome, e.g., age, dura-
tion of dialysis, remaining renal function, and related inflammatory disor-
ders.2,3,14–17
The aim of this study was to extract radiologic, laboratory and anamnestic
parameters that may be relevant for the onset and developement of dialysis
related amyloidosis. In addition to standard statistical procedures, we also
applied the machine-learning based methods of data mining to quantify the
risk factors for asymptomatic patients.
Extraction of risk factors for the onset of the dialysis related amyloidosis
syndrome could enable clinicians to predict the symptoms and consider
medical procedures to prevent the onset of the disease.
MATERIAL AND METHODS
Patients and Imaging Examinations
Real time sonography of the shoulders and knees was performed in 40 patients
receiving chronic haemodialysis as treatment of terminal renal failure. Linear trans-
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ducers of 7.5 and 10 Mhz were used. Plain radiographs of the shoulders and knees in
standard positions were taken simultaneously.
The group of patients consisted of 26 males and 14 females. Their mean age was
55.8 years (range 20–74 years). The mean duration of haemodialysis was 79.3 months
(range 12–211 months).
Criteria for clinical diagnosis of dialysis related amyloidosis were: persistent pain
and stiffness in both shoulders and knees lasting for more than 6 weeks and restric-
tion of movements in various degrees.5,6,18
Tendons were examined in 80 shoulders, evaluating the thickening of the rotator
cuff, of especially m. supraspinatus tendon. The thickness of supraspinatus was mea-
sured in both longitudinal and transversal views, in neutral position of the shoulder
and in the adduction, hyperextension and internal rotation of the arm. The mean
values between transversal and longitudinal views in both positions were calculated
as follows:
(i) Transverse view: superior of the head of humerus, just above the bicipital
groove, taken mid-point between symmetrical lateral narrowing of the tendon;
(ii) Longitudinal view: measured at the point where tendon emerges beneath
acromial shadow.6
During examination, texture of the tendons, especially inhomogencity, hyperechoic
amyloid deposits and small calcium deposits were observed.6,19
The knees were evaluated considering the presence of joint effusion and Baker’s
cysts. Shoulder measurements of 40 healthy volunteers and 60 patients taken dur-
ing other types of examinations in the USA were taken as referent points. Conven-
tional plain radiographs were analysed looking for the presence of calcifications of
the tendons and bursae.
Laboratory Examinations
Thirty-eight laboratory tests of peripheral blood biochemical parameters presented
in Table I were done periodically as a routine procedure during a one year prospec-
tive trial.
Data Analysis
Data were analysed by means of two software packages. STATISTICA for Win-
dows version 5.0 (http://www.StatSoft.com) was used for the estimation of Hotelling’s
T test and chi-square tests.20 Machine-learning analysis of biochemical and imaging
examinations was done with respect to the presence of characteristic joint symptoms
of dialysis related amyloidosis. The analysis was done by means of the C4.5 (J48)
machine learning classifier, with Weka (Waikato Environment for Knowledge Analy-
sis) software version 3.1.7.20–22 Weka is freely available at the World Wide Web ad-
dress http://www.cs.waikato.ac.nz/ml/weka.
C4.5 Machine-learning Program
The C4.5 program is a successor of the basic ID3 decision tree learning algo-
rithm.22–24 C4.5 defines the possible decision tree by means of a hill-climbing search
based on the statistical property measure called information gain.22–24 The elements
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of the tree generated by C4.5 are either leaves or decision nodes.22–24 The leaf shows
a class and the decision node specifies the test to be implemented on an attribute
value, with one branch and a subtree for each possible result of the test.22–24 The
starting node is the root node and the tree is used to predict a case by starting at the
root and moving through the tree until the leaf is encountered.22–24 For any tree, all
paths lead to a leaf corresponding to a decision rule that is a logical conjunction of
various tests.22–24
RESULTS AND DISCUSSION
We compared the results of biochemical tests and morphologic parame-
ters in patients with symptoms associated with dialysis related amyloidosis
and asymptomatic patients (Table I). In addition to elevated serum 2-micro-
globulin levels, previously reported by several authors, we also detected a
statistically significant rise in CRP, typical of chronic inflammation. Drop of
albumin values in patients with dialysis related amyloidosis in Table I may
be also linked to chronic inflammatory events. It is worth mentioning that
in symptomatic patients the duration of dialysis treatment was significantly
longer and that morphologic parameters in the knees showed no significant
differences between the groups.
As regards, morphologic parameters, significant differences were recorded
for sonographic inhomogeneity of the rotator cuff and RTG calcifications of
the rotator cuff (Table II). Thickening of the rotator cuff (Figure 1), espe-
cially the supraspinatus one was reported to be present in patients receiv-
ing a long-term dialysis.4,6,10,12 However, in this study, the sonographic in-
homogeneity of the rotator cuff, instead of the thickening of the rotator cuff,
was extracted as a parameter relevant for the diagnosis (Figure 2, Table II).
Inhomogeneity parameter that we found to be relevant for the discrimina-
tion of symptomatic and asymptomatic patients (Figure 2, Table II) is often
related to different pathological findings, including tissue deposits or micro-
trauma with bleeding, degeneration, fibrosis or inflammation.4 Consequently,
the inhomogeneity of the rotator cuff seems to be typical of the affected shoul-
der findings in dialysis related amyloidosis (Table II). RTG calcifications of
the rotator cuff are not necessarily associated with amyloidosis because they
appear in other dialysis complications and in other pathologic syndromes such
as impingement syndrome or calcific tendinitis.
In order to extract the algorithm linking the biochemical and morphologic
parameters to the diagnosis of the dialysis related amyloidosis, we have ap-
plied Quinlan’s C4.5 machine learning algorithm.22–24 The decision tree based
on the C4.5 algorithm is presented in Figure 2. Machine learning algorithm
extracted the sonographic inhomogeneity (SI) of the right shoulder rotator
cuff, duration of dialysis and 2-microglobulin serum levels as the parame-
ters that with 97.4% accuracy discriminate symptomatic from asymptomatic
938 I. BARI[I] ET AL.
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patients (Figure 2). Leave-one-out crossvalidation testing of the procedure’s
accurracy confirmed its validity by a very high overall classification of 87.18%
(Figure 2). The results of Table II are in line with the previously discussed
results of Table I and Figure 2. In addition to the biochemical parameter of
serum 2-microglobulin and the morphologic parameter of rotator cuff inhomo-
geneity, thought to be involved in the pathophysiological events of the dialysis
related amyloidosis, the tree also extracted the duration of the dialysis as
the essential parameter that discriminates the groups of symptomatic from
asymptomatic patients (Figure 2). The latter is consistant with literature
findings.1,4,5–7,12
The C4.5 machine learning algorithm enabled us to extract a simple and
highly accurate tree for the discrimination of asymptomatic and symptomatic
patients suffering from dialysis related amyloidosis. It remains an open ques-
tion if our findings may contribute to the problem of accurately predicting
the onset of dialysis related arthropathy in asymptomatic patients’ group.
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TABLE II
Morphologic parameters in patients with dialysis related amyloidosis and in
asymptomatic patients
Patients Sonographic inhomogeneity
of the rotator cuff / %a
RTG calcifications
of the rotator cuff / %b
Symptomatic 96.7 100
Asymptomatic 27.3 63.3
a p = 0.00001 (Yates corrected 2 = 24.71).
b p = 0.00430 (Yates corrected 2 = 8.15).
Figure 1. Thickening and inhomogeneity of the rotator cuff.
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a)
SI of right rotator cuff  0: negative (13.5)
SI of right rotator cuff > 0
 DURATION  18: negative (6.54)
 DURATION > 18
  2-M  15.9: negative (4.96/1.0)
  2-M > 15.9: positive (14.0)
Number of leaves: 4
Size of the tree: 7
Time taken to build the model: 0.05 seconds
b)
=== Evaluation on the training set (Summary) ===
Correctly classified instances 38 97.4359%
Incorrectly classified instances 1 2.5641%
Kappa statistic 0.9451
Mean absolute error 0.0409
Root mean squared error 0.1406
Relative absolute error 8.6262%
Root relative squared error 28.8963%
Total number of instances 39
=== Detailed accuracy by class ===
TP Rate FP Rate Precision Recall F-Measure Class
1 0.067 0.96 1 0.98 negative
0.933 0 1 0.933 0.966 positive
=== Confusion matrix ===
a b <-- classified as
24 0  a = negative
1 14  b = positive
=== Confusion matrix === LEAVE-ONE-OUT CROSSVALIDATION
a b <-- classified as
22 2  a = negative
3 12  b = positive
Figure 2. (a) C4.5 decision tree analysis of biochemical and morphologic parameters
relevant for the diagnosis of dialysis related amyloidosis; (b) Statistical evaluations
and procedure cross validation.
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SA@ETAK
Analiza biokemijskih i morfolo{kih pokazatelja u pacijenata
s amiloidozom u dijalizi zasnovana na strojnom u~enju
Igor Bari{i}, Vladimir Wilhelm, Nikola [tambuk, Ksenija Karaman,
Stipan Jankovi}, Pa{ko Konjevoda i Biserka Pokri}
Amiloidoza povezana s dijalizom jest nakupljanje i odlaganje fibrila 2-mikroglo-
bulina u kostima i zglobovima zbog nedovoljne eliminacije tijekom terapije ili sporo
progrediraju}eg zatajenja bubrega. Cilj rada bio je utvrditi biokemijske, morfolo{ke i
anamnesti~ke pokazatelje koji bi mogli biti zna~ajni za po~etak i razvoj amiloidoze
koja nastaje tijekom dijalize. Uz standardne statisti~ke metode, u radu su za analizu
podataka uporabljene i metode strojnog u~enja, radi kvantifikacije rizi~nih faktora
za asimptomatske pacijente. Izdvajanje rizi~nih faktora za pojavu sindroma amilo-
idoze u dijalizi moglo bi klini~aru omogu}iti predvi|anje po~etka simptoma i primje-
nu preventivnih medicinskih postupaka u cilju sprje~avanja po~etka bolesti. S pomo}u
algoritma C4.5 izdvojeno je jednostavno stablo visoke to~nosti za razlu~ivanje asimpto-
matskih od simptomatskih bolesnika s amiloidozom u dijalizi. Ostaje otvoreno pitanje
mogu li na{i rezultati pridonijeti to~nijem predvi|anju po~etka artropatije povezane
s dijalizom u skupini asimptomatskih bolesnika.
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